Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer T Fox

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
American Journal of Cancer Research|June 13, 2022
Oral administration of TRAIL-inducing small molecule ONC201/TIC10 prevents intestinal polyposis in the <i>Apc</i> <sup>min/+</sup> mouse modelVenkateshwar Madka, Arielle De La Cruz, Gopal Pathuri, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 26, 2022
Treatment Strategies and Mechanisms Associated with the Prevention of NASH-Associated HCC by a Toll-like Receptor 4 InhibitorSuet-Ying Kwan, Alyssa N Slayden, Aubrey R Coronado, et al.
Science Translational Medicine|August 19, 2021
The HIV protease inhibitor, ritonavir, corrects diverse brain phenotypes across development in mouse model of DYT-TOR1A dystoniaZachary F Caffall, Bradley J Wilkes, Ricardo Hernández-Martinez, et al.
The Journal of Biological Chemistry|September 30, 2016
Small Molecule Inhibition of the Ubiquitin-specific Protease USP2 Accelerates cyclin D1 Degradation and Leads to Cell Cycle Arrest in Colorectal Cancer and Mantle Cell Lymphoma ModelsMindy I Davis, Rajan Pragani, Jennifer T Fox, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
American Journal of Cancer Research|June 13, 2022
Oral administration of TRAIL-inducing small molecule ONC201/TIC10 prevents intestinal polyposis in the <i>Apc</i> <sup>min/+</sup> mouse modelVenkateshwar Madka, Arielle De La Cruz, Gopal Pathuri, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 26, 2022
Treatment Strategies and Mechanisms Associated with the Prevention of NASH-Associated HCC by a Toll-like Receptor 4 InhibitorSuet-Ying Kwan, Alyssa N Slayden, Aubrey R Coronado, et al.
Science Translational Medicine|August 19, 2021
The HIV protease inhibitor, ritonavir, corrects diverse brain phenotypes across development in mouse model of DYT-TOR1A dystoniaZachary F Caffall, Bradley J Wilkes, Ricardo Hernández-Martinez, et al.
The Journal of Biological Chemistry|September 30, 2016
Small Molecule Inhibition of the Ubiquitin-specific Protease USP2 Accelerates cyclin D1 Degradation and Leads to Cell Cycle Arrest in Colorectal Cancer and Mantle Cell Lymphoma ModelsMindy I Davis, Rajan Pragani, Jennifer T Fox, et al.
Pageof 3